A detailed history of British Columbia Investment Management Corp transactions in Johnson & Johnson stock. As of the latest transaction made, British Columbia Investment Management Corp holds 401,576 shares of JNJ stock, worth $62.3 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
401,576
Previous 461,569 13.0%
Holding current value
$62.3 Million
Previous $67.5 Million 3.53%
% of portfolio
0.41%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $8.73 Million - $10 Million
-59,993 Reduced 13.0%
401,576 $65.1 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $25 Million - $27.3 Million
173,170 Added 60.05%
461,569 $67.5 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $1.74 Million - $1.82 Million
11,203 Added 4.04%
288,399 $45.6 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $8.46 Million - $9.23 Million
58,099 Added 26.52%
277,196 $43.4 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $2.48 Million - $2.78 Million
-15,936 Reduced 6.78%
219,097 $34.1 Million
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $191,394 - $205,976
1,240 Added 0.53%
235,033 $38.9 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $71,597 - $85,443
474 Added 0.2%
233,793 $36.2 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $4.4 Million - $4.93 Million
-27,444 Reduced 10.52%
233,319 $41.2 Million
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $7.2 Million - $8.01 Million
-44,619 Reduced 14.61%
260,763 $42.6 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $17.1 Million - $18.9 Million
-101,505 Reduced 24.95%
305,382 $54.2 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $8.87 Million - $10.1 Million
-56,075 Reduced 12.11%
406,887 $72.1 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $3.77 Million - $4.18 Million
-24,161 Reduced 4.96%
462,962 $79.2 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $87,210 - $96,913
540 Added 0.11%
487,123 $78.7 Million
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $8.68 Million - $9.31 Million
54,449 Added 12.6%
486,583 $80.2 Million
Q1 2021

Apr 30, 2021

SELL
$153.07 - $170.48 $2.08 Million - $2.32 Million
-13,582 Reduced 3.05%
432,134 $71 Million
Q4 2020

Feb 02, 2021

SELL
$137.11 - $157.38 $1.65 Million - $1.9 Million
-12,059 Reduced 2.63%
445,716 $70.1 Million
Q3 2020

Nov 10, 2020

BUY
$140.38 - $153.83 $4.96 Million - $5.44 Million
35,336 Added 8.36%
457,775 $68.2 Million
Q2 2020

Aug 12, 2020

BUY
$128.81 - $155.51 $17.3 Million - $20.9 Million
134,562 Added 46.74%
422,439 $59.4 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $48.3 Million - $67 Million
-434,899 Reduced 60.17%
287,877 $37.7 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $12.1 Million - $13.9 Million
-94,720 Reduced 11.59%
722,776 $105 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $12.6 Million - $14.2 Million
-99,565 Reduced 10.86%
817,496 $106 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $4.34 Million - $4.77 Million
-33,086 Reduced 3.48%
917,061 $128 Million
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $16.5 Million - $18.3 Million
-131,045 Reduced 12.12%
950,147 $133 Million
Q4 2018

Feb 13, 2019

BUY
$122.84 - $147.84 $10.3 Million - $12.4 Million
84,120 Added 8.44%
1,081,192 $140 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $36.9 Million - $43.4 Million
-303,627 Reduced 23.34%
997,072 $138 Million
Q2 2018

Aug 09, 2018

SELL
$119.4 - $131.76 $33.6 Million - $37.1 Million
-281,298 Reduced 17.78%
1,300,699 $158 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $11.4 Million - $13.5 Million
-91,053 Reduced 5.44%
1,581,997 $203 Million
Q4 2017

Feb 20, 2018

BUY
$131.22 - $143.62 $7.2 Million - $7.88 Million
54,896 Added 3.39%
1,673,050 $234 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $210 Million - $219 Million
1,618,154
1,618,154 $210 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.